[Activity Report] The 11th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 23, 2024)
date : 11/7/2024
Tags: AMR
![[Activity Report] The 11th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 23, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/71B93003-806C-4A1D-A662-EFE4D4457443_1_201_a-scaled-1.jpeg)
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed innovation needed to address antimicrobial resistance (AMR) during the “Agenda4 Innovation” in the 11th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-organized by THE FINANCIAL TIMES LTD.
During the meeting, AMR Consortium Co-Chair Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University School of Medicine) shared his views on potential innovative solutions to combat AMR, including advancements in the field of drug discovery, vaccine development, bacteriophage therapy, diagnostic methods, approaches utilizing bacterial flora, as well as antibody drugs. He also reflected on the achievements of the AMR Consortium’s activities and policy development on AMR. The pressing need for a pull-type incentive system and the establishment of a drug discovery ecosystem that contributes to infection control measures were also mentioned during the discussion, and participants agreed on its importance and urgency.
[Overview]
- Date: Wednesday, October 23, 2024
- Program: Agenda4 Innovation
Related Posts
-
2024-11-05
[Lecture Report] The 11th NIKKEI FT Communicable Diseases Conference -Building a Crisis-Resilient Society (Nikkei Inc., October 22-23, 2024, Chiyoda-ku, Tokyo)
-
2024-10-07
[Event Report] The 9th Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference – Asia Africa Medical Innovation Consortium (AMIC) (October 3, 2024)
-
2023-12-07
[Activity Report] The 10th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 17, 2023)
-
2023-12-07
[Lecture Report] The 10th NIKKEI FT Communicable Diseases Conference (Nikkei Inc., October 16-18, 2023, Tokyo, Chiyoda-ku)
-
2024-09-26
[Event Report] UN General Assembly High-Level Meeting on AMR Side Event “Global Action on AMR: Advancing Healthy Longevity and Sustainability under UHC” (September 25, 2024)
-
2024-06-21
[Event Report] HGPI Special Seminar “HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future” (January 16, 2024)
-
2024-06-10
[Lecture Report] Abu Dhabi Global Healthcare Week (ADGHW) (May 14, 2024, Abu Dhabi, UAE)
-
2024-04-25
[Lecture Report] The World Dementia Council “WDC Summit 2024” (March 26, 2024, London, England)
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
